ORLY
60
-5
CB
57
2
YUM
43
-6
CMS
60
2
WM
74
-5
DVN
14
-6
HSY
31
-6
DRI
50
-3
SWK
50
-5
IFF
47
-4
EW
32
3
LMT
30
-2
DTE
43
5
IBM
47
-3
AVGO
18
-9
RRC
52
-6
GD
41
-4
BDX
56
10
UAL
83
-2
FOXA
52
-14
ORLY
60
-5
CB
57
2
YUM
43
-6
CMS
60
2
WM
74
-5
DVN
14
-6
HSY
31
-6
DRI
50
-3
SWK
50
-5
IFF
47
-4
EW
32
3
LMT
30
-2
DTE
43
5
IBM
47
-3
AVGO
18
-9
RRC
52
-6
GD
41
-4
BDX
56
10
UAL
83
-2
FOXA
52
-14
Financhill
Back

European Equity Fund,/ MD Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
30

EEA
European Equity Fund,/ MD

Last Price:
8.49
Seasonality Move:
2.48%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
30
European Equity Fund,/ MD (EEA) is a Sell

Is European Equity Fund,/ MD a Buy, Sell or Hold?

  • The current European Equity Fund,/ MD [EEA] share price is $8.48. The Score for EEA is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • EEA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EEA Stock Price Chart

What is European Equity Fund,/ MD's stock price today?

  • The European Equity Fund,/ MD share price today is $8.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EEA is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

EEA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 30.87 Sell
Chaikin Money Flow: -20019 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.64 - 8.98) Sell
Bollinger Bands (100): (8.81 - 9.27) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

EEA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.6 Sell
20-day SMA: 8.76 Sell
50-day SMA: 9.02 Sell
200-day SMA: 8.96 Sell
8-day EMA: 8.59 Sell
20-day EMA: 8.74 Sell
50-day EMA: 8.92 Sell
200-day EMA: 8.9 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

European Equity Fund,/ MD Earnings Growth & EEA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

European Equity Fund,/ MD Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):